Dr Sue Astley
University of Manchester
Sue Astley leads research in breast radiomics at the University of Manchester. Her work includes evaluation of novel imaging technologies (CAD, DBT), developing software to detect abnormalities and discover imaging biomarkers, using eye tracking to learn how new imaging systems are best employed, and working closely with radiologists to achieve clinically useful solutions. As breast density lead for the 55,000 strong Predicting Risk of Cancer At Screening (PROCAS) study she has focused her attention on markers of breast cancer risk, harnessing the power of deep learning to exploit the trial data and improve risk prediction.
Deep learning for breast density assessment and risk prediction
I will review the importance of breast density assessment for cancer risk prediction, identifying women for whom mammography is less effective, and assessing the efficacy of risk reducing interventions. I will then discuss current methods for density assessment, looking at the strengths and limitations of different approaches. Finally, I will describe density assessment using convolutional neural networks, including a review of the issues associated with developing and validating such approaches.
EVEN MORE SEMINARS
Professor Paul Leeson University of Oxford
Is AI about to revolutionise cardiovascular ultrasound diagnostics?
Matthew Gardner RRPPS, University Hospitals Birmingham NHS Foundation Trust
Patient dosimetry audit for nuclear medicine and radiotherapy planning CT
Andy Rogers – Lead Interventional MPE Nottingham University Hospitals NHS Trust
Integrating interventional procedure data to improve clinician feedback – new technology gains maturity
Dr Simeon Nill The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
MR image-guided radiotherapy treatment on the MR-Linac
Professor Feng Wu University of Oxford
Focused Ultrasound Therapy for Tumours: Current Status and Future Prospective